Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-5,page-paged-5,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

CLIENT NEWS

 

 

  • ViGeneron and WuXi Advanced Therapies enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy
    01 December 2020
    www.vigeneron.com
  • DR. Jürgen Beck scheidet zum 31. Dezember 2020 scheidet zum 31. Dezember 2020 planmäßig aus dem Vorstand der Paion AG aus
    01 December 2020
    www.paion.com
  • Abivax completes recruitment of ABX464 Phase 2b induction study in ulcerative colitis
    30 November 2020
    www.abivax.com
  • Adrenomed AG: Adrenomed closes EUR 22 million equity financing to accelerate development of Adrecizumab (HAM8101) and provides business update
    30 November 2020
    www.andrenomed.com
  • Marinomed Biotech AG announces clinical trial at Swansea University Medical School to investigate efficacy of Carragelose in preventing COVID-19 infections
    30 November 2020
    www.marinomed.com
  • CENTOGENE GmbH: CENTOGENE Expands Express COVID-19 Antigen Testing to Frankfurt Airport
    26 November 2020
    www.centogene.com
  • Marinomed Biotech reports record sales in the first nine months of 2020 and a positive outlook
    26 November 2020
    www.marinomed.com
  • Correction: NeuroRx and Relief announce initial successful results from expanded access use of RLF-100™ (aviptadil) in patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients
    25 November 2020
    www.relieftherapeutics.com
  • CENTOGENE GmbH: CENTOGENE eröffnet Walk-In-COVID-19-Testzentrum in Wiesbadener Innenstadt
    25 November 2020
    www.centogene.com
  • NeuroRx and Relief announce initial successful results from expanded access use of RLF-100™ (aviptadil) in patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients
    24 November 2020
    www.relieftherapeutics.com